By Matthew Bultman ( April 12, 2017, 8:47 PM EDT) -- Roxane Laboratories Inc. could be on the hook for upward of $2 million in legal fees, after a New Jersey federal judge decided Wednesday the infringement claim it brought against two generic-drug makers over a kidney medication patent was unreasonable....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.